Open Source Today
  • About
  • OST Original Articles
  • Patents That Kill

    by Ben Pearson
    August 12th, 2014

    The patent system was developed independently in 15th century Venice and was expanded upon to include temporary monopolies in 17th century England. By the 1860’s many had begun questioning the effectiveness of the patent system, and recent research has backed up the claim that patents stifle innovation. The pharmaceutical industry has been one of the biggest defenders of the patent system by arguing it is needed to recoup the exorbitant costs of drug R&D and clinical trials. Often, drug companies only get a few years to recoup their investments; this forms the basis of their defense of the patent system. However, this research demonstrates that our current patent system encourages these companies to pursue the development of drugs for people that are not likely to survive their diseases in the first place, leaving a those that could be cured out to dry.

    More from The Economist

    • Governance
    • Technology
  • Also in Governance, Technology

    • Linux Foundation Launches LF Edge to Establish an Open Source Framework for the Edge
    • EU to Provide Nearly $1M for Open Source Bug Bounty Program
    • Badgy: An Open Source E Ink Badge
    • NASA Releases an Open Source Rover

      Related posts:

      1. Can Open Science Help Patients and Save Pharma?
      2. Number of Companies Using The Patent System is ‘Surprisingly Small’
      3. Patent Troll Cases Heard by US Supreme Court
      4. North Carolina Says “No” to Patent Trolls

    Search

Home Page
Creative Commons License

Open Source Today is licensed under a

Creative Commons Attribution-ShareAlike 4.0 International License.

Theme Design by

Ben Lloyd Pearson